Ren et al. (2021) demonstrated that NEAT1 suppressed miR-218-5p and accelerated the expression of tumor protein D52 (TPD52), which is already known to be upregulated in breast cancer (Wang et al. 2022), and is correlated with worse clinicopathological features in breast cancer patients (Roslan et al. 2014). The gene discussed is TPD52; the disease is breast cancer.